Recent advances in Helicobacter pylori eradication.

about

Infection and Its Risk Factors: A Prospective Cross-Sectional Study in Resource-Limited Settings of Northwest Ethiopia

P2860

Q58699321-22C51575-644D-455E-8521-04AE0DE4C7A8

P2860

Recent advances in Helicobacter pylori eradication.

Item

http://www.wikidata.org/entity/Q42090635

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Recent advances in Helicobacter pylori eradication.

@en

Recent advances in Helicobacter pylori eradication.

@nl

type

Item

label

Recent advances in Helicobacter pylori eradication.

@en

Recent advances in Helicobacter pylori eradication.

@nl

prefLabel

Recent advances in Helicobacter pylori eradication.

@en

Recent advances in Helicobacter pylori eradication.

@nl

P1476

Recent advances in Helicobacter pylori eradication

@en

P2093

Theodore Rokkas

http://www.w3.org/2001/XMLSchema#string

Yaron Niv

http://www.w3.org/2001/XMLSchema#string

P2860

Optimum duration of regimens for Helicobacter pylori eradication

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials.

High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.

Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials.

High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection

High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study.

Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence

P304

415-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26424053

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

4585385

http://www.w3.org/2001/XMLSchema#string

Recent advances in Helicobacter pylori eradication.

about

P2860

P2860

Recent advances in Helicobacter pylori eradication.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932